Transcriptional Regulation of the Stem Cell Leukemia Gene by PU.1 and Elf-1*

The SCL gene, also known astal-1, encodes a basic helix-loop-helix transcription factor that is pivotal for the normal development of all hematopoietic lineages. SCL is expressed in committed erythroid, mast, and megakaryocytic cells as well as in hematopoietic stem cells. Nothing is known about the regulation of SCL transcription in mast cells, and in other lineages GATA-1 is the only tissue-specific transcription factor recognized to regulate the SCL gene. We have therefore analyzed the molecular mechanisms underlyingSCL expression in mast cells. In this paper, we demonstrate that SCL promoter 1a was regulated by GATA-1 together with Sp1 and Sp3 in a manner similar to the situation in erythroid cells. However, SCL promoter 1b was strongly active in mast cells, in marked contrast to the situation in erythroid cells. Full activity of promoter 1b was dependent on ETS and Sp1/3 motifs. Transcription factors PU.1, Elf-1, Sp1, and Sp3 were all present in mast cell extracts, bound to promoter 1b and transactivated promoter 1b reporter constructs. These data provide the first evidence that theSCL gene is a direct target for PU.1, Elf-1, and Sp3.

[1]  B. Göttgens,et al.  Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements , 1997, Oncogene.

[2]  M. Triggiani,et al.  Molecular and cellular biology of mast cells and basophils. , 1997, International archives of allergy and immunology.

[3]  E. Morii,et al.  Involvement of transcription factor encoded by the mouse mi locus (MITF) in expression of p75 receptor of nerve growth factor in cultured mast cells of mice. , 1997, Blood.

[4]  J. Licht,et al.  Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.

[5]  C. Croce,et al.  Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade , 1997, Molecular and cellular biology.

[6]  D. Metcalfe,et al.  Two different negative regulatory elements control the transcription of T-cell activation gene 3 in activated mast cells. , 1997, Biochemical Journal.

[7]  E. Scott,et al.  PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. , 1997, Immunity.

[8]  B. Göttgens,et al.  Distinct Mechanisms Direct SCL/tal-1 Expression in Erythroid Cells and CD34 Positive Primitive Myeloid Cells* , 1997, The Journal of Biological Chemistry.

[9]  J. Palis,et al.  Initiation of murine embryonic erythropoiesis: a spatial analysis. , 1997, Blood.

[10]  R. Maki,et al.  Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. , 1997, Journal of immunology.

[11]  R. Walsh,et al.  Selective Reporter Expression in Mast Cells Using a Chymase Promoter* , 1997, The Journal of Biological Chemistry.

[12]  A. Scheffold,et al.  P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues , 1997, Nature.

[13]  A. Bassuk,et al.  The role of Ets transcription factors in the development and function of the mammalian immune system. , 1997, Advances in immunology.

[14]  M. Turner,et al.  Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. , 1996, Oncogene.

[15]  M. Roussel,et al.  A potential role for Elf-1 in terminal transferase gene regulation , 1996, Molecular and cellular biology.

[16]  T. Libermann,et al.  ELF-1 Interacts with and Transactivates the IgH Enhancer π Site* , 1996, The Journal of Biological Chemistry.

[17]  T. Green.  Master regulator unmasked , 1996, Nature.

[18]  S. Mckercher,et al.  PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells. , 1996, Blood.

[19]  M. Beato,et al.  An inhibitor domain in Sp3 regulates its glutamine‐rich activation domains. , 1996, The EMBO journal.

[20]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[21]  E. Morii,et al.  Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. , 1996, Blood.

[22]  C. Begley,et al.  The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. , 1996, The EMBO journal.

[23]  F. Alt,et al.  The T Cell Leukemia Oncoprotein SCL/tal-1 Is Essential for Development of All Hematopoietic Lineages , 1996, Cell.

[24]  M. Roussel,et al.  Cloning and expression of the murine Elf-1 cDNA. , 1996, Gene.

[25]  M. Ichihara,et al.  Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response. , 1996, Blood.

[26]  W. Leonard,et al.  Importance of low affinity Elf-1 sites in the regulation of lymphoid- specific inducible gene expression , 1996, The Journal of experimental medicine.

[27]  F. Moreau-Gachelin,et al.  Differential phosphorylations of Spi-B and Spi-1 transcription factors. , 1996, Oncogene.

[28]  G. Henkel,et al.  Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex , 1996, Molecular and cellular biology.

[29]  S. Cogoi,et al.  Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Scott,et al.  PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. , 1995, Immunity.

[31]  C. Begley,et al.  Lineage-restricted regulation of the murine SCL/TAL-1 promoter. , 1995, Blood.

[32]  N. Speck,et al.  Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins , 1995, Journal of virology.

[33]  C. Begley,et al.  Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Amylon,et al.  Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. , 1995, Blood.

[35]  B. Göttgens,et al.  Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation. , 1995, Oncogene.

[36]  M. Komaromy,et al.  Site-directed mutagenesis using thermostable enzymes. , 1995, BioTechniques.

[37]  P. Romeo,et al.  Loss of TAL‐1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. , 1995, The EMBO journal.

[38]  Stuart H. Orkin,et al.  Transcription Factors and Hematopoietic Development (*) , 1995, The Journal of Biological Chemistry.

[39]  W. Leonard,et al.  Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins , 1995, Molecular and cellular biology.

[40]  N. Copeland,et al.  The murine interleukin-3 receptor alpha subunit gene: chromosomal localization, genomic structure, and promoter function. , 1995, Blood.

[41]  S. Orkin,et al.  Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.

[42]  D. Mason,et al.  Expression of TAL-1 proteins in human tissues. , 1995, Blood.

[43]  S. Orkin,et al.  Hematopoiesis: how does it happen? , 1995, Current opinion in cell biology.

[44]  F. Moreau-Gachelin.  Spi-1/PU.1: an oncogene of the Ets family. , 1994, Biochimica et biophysica acta.

[45]  J. D. Engel,et al.  Vintage reds and whites: combinatorial transcription factor utilization in hematopoietic differentiation. , 1994, Current opinion in genetics & development.

[46]  A. Green,et al.  Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line. , 1994, Oncogene.

[47]  S. Hedrick,et al.  Elf-1 binds to a critical element in a second CD4 enhancer , 1994, Molecular and cellular biology.

[48]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[49]  O. Bernard,et al.  GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. , 1994, Oncogene.

[50]  G. Henkel,et al.  PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Beato,et al.  Sp1‐mediated transcriptional activation is repressed by Sp3. , 1994, The EMBO journal.

[52]  A. Green,et al.  Transcription factors and the regulation of haemopoiesis: Lessons from GATA and SCL proteins , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[53]  G. Keller,et al.  Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. , 1994, Genes & development.

[54]  J. Jordan,et al.  The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis , 1994 .

[55]  R. Hromas,et al.  Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core , 1994, Molecular and cellular biology.

[56]  T. Bieber.  FcϵRI on human Langerhans cells: a receptor in search of new functions , 1994 .

[57]  C. Y. Wang,et al.  Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors , 1994, Molecular and cellular biology.

[58]  J. Visvader,et al.  Structure of the gene encoding the murine SCL protein. , 1994, Gene.

[59]  A. Nordheim,et al.  Gene regulation by Ets proteins. , 1993, Biochimica et biophysica acta.

[60]  J. Ghysdael,et al.  A single amino-acid substitution in the Ets domain alters core DNA binding specificity of Ets1 to that of the related transcription factors Elf1 and E74. , 1993, Nucleic acids research.

[61]  N. Oppenheimer-Marks,et al.  Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen. , 1993, Oncogene.

[62]  S. Emerson,et al.  Molecular regulation of the human IL-3 gene: inducible T cell- restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites , 1993, The Journal of experimental medicine.

[63]  J. O'prey,et al.  Transcriptional up-regulation of the mouse cytosolic glutathione peroxidase gene in erythroid cells is due to a tissue-specific 3' enhancer containing functionally important CACC/GT motifs and binding sites for GATA and Ets transcription factors , 1993, Molecular and cellular biology.

[64]  D. Markovitz,et al.  Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor , 1993, Journal of virology.

[65]  C. Begley,et al.  The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. Y. Wang,et al.  Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. , 1993, Science.

[67]  D. Housman,et al.  Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis , 1993, Molecular and cellular biology.

[68]  M. Klemsz,et al.  Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. , 1993, Science.

[69]  Andrew J. Bannister,et al.  The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[70]  W. Vainchenker,et al.  Expression of tal-1 and GATA-binding proteins during human hematopoiesis. , 1993, Blood.

[71]  S. Galli,et al.  New concepts about the mast cell. , 1993, The New England journal of medicine.

[72]  B. Wasylyk,et al.  The Ets family of transcription factors. , 1993, European journal of biochemistry.

[73]  S. Orkin,et al.  The SCL gene product: a positive regulator of erythroid differentiation. , 1992, The EMBO journal.

[74]  C. Y. Wang,et al.  A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells , 1992, Journal of virology.

[75]  J. Visvader,et al.  SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. , 1992, Oncogene.

[76]  A. Elefanty,et al.  bcr-abl-Induced cell lines can switch from mast cell to erythroid or myeloid differentiation in vitro. , 1992, Blood.

[77]  L. Zon,et al.  GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. , 1991, The Journal of biological chemistry.

[78]  A. Green,et al.  Antisense SCL suppresses self‐renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. , 1991, The EMBO journal.

[79]  A. Green,et al.  Erythroid expression of the 'helix-loop-helix' gene, SCL. , 1991, Oncogene.

[80]  T. Kouzarides,et al.  The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. , 1991, Oncogene.

[81]  J. Visvader,et al.  Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[82]  S. Orkin,et al.  Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. , 1990, Genes & development.

[83]  M. Siciliano,et al.  Site‐specific recombination of the tal‐1 gene is a common occurrence in human T cell leukemia. , 1990, The EMBO journal.

[84]  M. Klemsz,et al.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene , 1990, Cell.

[85]  A. Carroll,et al.  The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix‐loop‐helix protein. , 1990, The EMBO journal.

[86]  P. Nowell,et al.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[87]  C. Asselin,et al.  Molecular requirements for transcriptional initiation of the murine c-myc gene. , 1989, Oncogene.

[88]  T. Waldmann,et al.  Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[89]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[90]  M. Plumb,et al.  Detection of Sequence-Specific Protein-DNA Interactions by the DNA-Footprinting Technique. , 1988, Methods in molecular biology.

[91]  S. Morrison,et al.  Immunoglobulin gene expression in transformed lymphoid cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[92]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[93]  I. Schneider,et al.  Cell lines derived from late embryonic stages of Drosophila melanogaster. , 1972, Journal of embryology and experimental morphology.